  The thalamus and its constituent nuclei are critical for a broad range of
cognitive and sensorimotor processes, and implicated in many neurological and
neurodegenerative conditions. However, the functional involvement and
specificity of thalamic nuclei in human neuroimaging is underappreciated and
not well studied due, in part, to technical challenges of accurately
identifying and segmenting nuclei. This challenge is further exacerbated by a
lack of common nomenclature for comparing segmentation methods. Here, we use
data from healthy young (Human Connectome Project, 100 subjects) and older
healthy adults, plus those with minor cognitive impairment and Alzheimer$'$s
disease (Alzheimer$'$s Disease Neuroimaging Initiative, 540 subjects), to
benchmark four state of the art thalamic segmentation methods for T1 MRI
(FreeSurfer, HIPS-THOMAS, SCS-CNN, and T1-THOMAS) under a single segmentation
framework. Segmentations were compared using overlap and dissimilarity metrics
to the Morel stereotaxic atlas. We also quantified each method$'$s estimation
of thalamic nuclear degeneration across Alzheimer$'$s disease progression, and
how accurately early and late mild cognitive impairment, and Alzheimers disease
could be distinguished from healthy controls. We show that HIPS-THOMAS produced
the most effective segmentations of individual thalamic nuclei and was also
most accurate in discriminating healthy controls from those with mild cognitive
impairment and Alzheimer$'$s disease using individual nucleus volumes. This
work is the first to systematically compare the efficacy of anatomical thalamic
segmentation approaches under a unified nomenclature. We also provide
recommendations of which segmentation method to use for studying the functional
relevance of specific thalamic nuclei, based on their overlap and dissimilarity
with the Morel atlas.
